These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24337703)

  • 1. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.
    Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ
    Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
    Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
    Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
    Kotamraju S; Williams CL; Kalyanaraman B
    Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
    Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
    Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
    Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
    Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
    Knight LA; Kurbacher CM; Glaysher S; Fernando A; Reichelt R; Dexel S; Reinhold U; Cree IA
    BMC Cancer; 2009 Jan; 9():38. PubMed ID: 19175937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluvastatin induces apoptosis on human tongue carcinoma cell line HSC-3].
    Fujiwara K; Tsubaki M; Yamazoe Y; Nishiura S; Kawaguchi T; Ogaki M; Nishinobo M; Shimamoto K; Moriyama K; Nishida S
    Yakugaku Zasshi; 2008 Jan; 128(1):153-8. PubMed ID: 18176067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.
    Meroni PL; Raschi E; Testoni C; Tincani A; Balestrieri G; Molteni R; Khamashta MA; Tremoli E; Camera M
    Arthritis Rheum; 2001 Dec; 44(12):2870-8. PubMed ID: 11762948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
    Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
    Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells.
    Sekiya A; Morishita E; Maruyama K; Torishima H; Ohtake S
    J Atheroscler Thromb; 2015 Jul; 22(7):660-8. PubMed ID: 25735397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.
    Kanugula AK; Gollavilli PN; Vasamsetti SB; Karnewar S; Gopoju R; Ummanni R; Kotamraju S
    FEBS J; 2014 Aug; 281(16):3719-38. PubMed ID: 24964743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival.
    Musso A; Zocchi MR; Poggi A
    Haematologica; 2011 Jan; 96(1):16-23. PubMed ID: 20884711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy.
    Ogata Y; Takahashi M; Takeuchi K; Ueno S; Mano H; Ookawara S; Kobayashi E; Ikeda U; Shimada K
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):907-15. PubMed ID: 12451324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Inoue M; Nakamura H
    Gastroenterology; 2002 Feb; 122(2):308-17. PubMed ID: 11832446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
    Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
    Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects.
    Kolawole EM; McLeod JJ; Ndaw V; Abebayehu D; Barnstein BO; Faber T; Spence AJ; Taruselli M; Paranjape A; Haque TT; Qayum AA; Kazmi QA; Wijesinghe DS; Sturgill JL; Chalfant CE; Straus DB; Oskeritzian CA; Ryan JJ
    J Immunol; 2016 Feb; 196(4):1461-70. PubMed ID: 26773154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.
    Goard CA; Mather RG; Vinepal B; Clendening JW; Martirosyan A; Boutros PC; Sharom FJ; Penn LZ
    Int J Cancer; 2010 Dec; 127(12):2936-48. PubMed ID: 21351272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.